There’s a common organizational saying: structure drives behaviour. In institutional theory, it’s called path dependence.

Biotech hot picks spotlight Xenon, United Therapeutics and Axsome as Phase III data and FDA decisions approach.

Insights on withdrawal risks, gradual tapering strategies, and patient-centered support It’s about supporting the ...

A recent study evaluated 600 adults with depression. Over 80% of participants experienced significant symptom improvement with a ...

A FORMER beauty queen was called a “zombie” by cruel trolls after her skin suddenly erupted in acne and “cysts the size of ...

There are many people experiencing trauma in their lives for which they receive counselling, hormones, medications, sedatives. These are many people born with conditions or who develop them later in ...

A science-backed roadmap to address blood sugar dysfunction before it becomes irreversible disease If people understand ...

A step-by-step psychological guide to stopping cravings and overeating - as revealed in a new book from Daily Mail columnist ...

On Feb. 20, 2003, a fire ripped through The Station in West Warwick, Rhode Island, leaving 100 people dead and more than 200 ...

The use of testosterone is rising rapidly among Swedish men, and online the hormone is often sold as an elixir of masculinity ...

Seaport Therapeutics ("Seaport" or the "Company"), a clinical-stage therapeutics company advancing novel neuropsychiatric medicines with a proven strategy and team, today announced the presentation of ...